Biotech companies in the United States by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Biogen has the lowest figure of the 18 biotech companies in the United States ranked by P/B ratio, at 2.0, followed by Vaxcyte (3.4) and Neurocrine Biosciences (4.0). Figures as of 20 Nov 2026, 20:04 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
18
Lowest
Biogen2.0
Median
8.3
Combined market value
SGD 944.4B
Countries
1
Not ranked
2no P/B ratio on file

Market values as of .

United States
All sectors
Biotech
SGD
Clear filters
Biotech companies in the United States by P/B ratio
#CompanyP/B ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care2.0SGD 47.7BSGD 322.46 1.14% up 41% up United States
2VaxcytePCVX · Health Care3.4SGD 11.4BSGD 72.08 4.26% down 22% up United States
3Neurocrine BiosciencesNBIX · Health Care4.0SGD 19.8BSGD 195.70 3.13% down 10% up United States
4RepligenRGEN · Health Care4.5SGD 13.6BSGD 212.08 3.46% down 5% up United States
5Bio-TechneTECH · Health Care5.3SGD 14.7BSGD 93.82 0.03% up 18% up United States
6Kymera TherapeuticsKYMR · Health Care6.1SGD 12.7BSGD 148.49 3.60% down 81% up United States
7Krystal BiotechKRYS · Health Care6.4SGD 11.9BSGD 401.77 1.39% down 49% up United States
8CG OncologyCGON · Health Care7.2SGD 9.3BSGD 103.60 1.95% down 93% up United States
9Twist BioscienceTWST · Health Care7.9SGD 9.1BSGD 134.18 6.82% down 291% up United States
10ExelixisEXEL · Health Care8.7SGD 20.5BSGD 84.02 1.07% down 55% up United States
11ImmunovantIMVT · Health Care10.0SGD 8.5BSGD 41.14 1.94% down 44% up United States
12ModernaMRNA · Health Care11.5SGD 101.7BSGD 251.34 2.26% down 740% up United States
13Revolution MedicinesRVMD · Health Care14.5SGD 45BSGD 208.25 1.25% up 125% up United States
14Gilead SciencesGILD · Health Care16.0SGD 268.8BSGD 216.71 0.87% up 31% up United States
15AmgenAMGN · Health Care16.5SGD 306.2BSGD 566.01 0.56% up 30% up United States
16Adaptive BiotechnologiesADPT · Health Care25.2SGD 5.8BSGD 35.52 1.84% down 51% up United States
17Scholar Rock HoldingSRRK · Health Care35.2SGD 7.7BSGD 62.80 3.36% down 25% up United States
18Kodiak SciencesKOD · Health Care498SGD 8.2BSGD 125.97 0.27% down 371% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2901 SGD). 2 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which biotech companies in the United States have the lowest P/B ratio?

Biogen (2.0), Vaxcyte (3.4) and Neurocrine Biosciences (4.0) have the lowest P/B ratio of the 18 biotech companies in the United States ranked here as of 20 Nov 2026, 20:04 UTC.

How many biotech companies in the United States are in this ranking?

18 are ranked by P/B ratio. 2 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 18 biotech companies in the United States ranked by P/B ratio have a combined market value of SGD 944.4B as of 20 Nov 2026, 20:04 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Biotech companies in the United States by P/B ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.